Skip to main content

Advertisement

SpringerLink
Log in

Elevated fractalkine in patients with obstructive sleep apnea hypopnea syndrome

  • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Background

Obstructive sleep apnea hypopnea syndrome (OSAHS) has been increasingly linked to cardiovascular disease. Inflammatory processes associated with OSAHS may contribute to artherosclerosis in these patients. Fractalkine is a unique chemokine which has both adhesive and chemoattractant functions. We tested the hypothesis that OSAHS patients have increased fractalkine.

Methods and results

We studied 20 patients (18 males and 2 females) with newly diagnosed OSAHS, who were free of other diseases, had never been treated for OSAHS, and were taking no medications. We compared fractalkine measurements in these patients to measurements obtained in 15 control subjects (14 males and 1 female) who were matched for age and body mass index, and in whom occult OSAHS was excluded. Plasma fractalkine levels were significantly higher in patients with OSAHS than in controls (463.15 ± 110.78 versus 364.67 ± 64.81 pg/mL, F = 2.58, P = 0.004). Fractalkine were associated with AHI (r = 0.756, P < 0.0001), lowest oxygen saturation (r = −0.466, P = 0.005), and mean oxygen saturation (r = −0.344, P = 0.043). Plasma fractalkine levels were significantly decreased in patients with OSAHS after four nights nCPAP (463.15 ± 110.78 versus 416.75 ± 97.67 pg/mL, P = 0.001).

Conclusions

OSAHS is associated with elevated levels of fractalkine, a marker of inflammation related to artherosclerosis. The severity of OSAHS is proportional to the fractalkine level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Fava C, Montagnana M, Favaloro EJ, Guidi GC, Lippi G (2011) Obstructive sleep apnea syndrome and cardiovascular diseases. Semin Thromb Hemost 37:280–297

    Article  PubMed  Google Scholar 

  2. Drager LF, Polotsky VY, Lorenzi-Filho G (2011) Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 140:534–542

    Article  PubMed  Google Scholar 

  3. Quercioli A, Mach F, Montecucco F (2010) Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). Sleep Breath 14:261–269

    Article  PubMed  Google Scholar 

  4. Williams A, Scharf SM (2007) Obstructive sleep apnea, cardiovascular disease, and inflammation—is NF-kappa B the key? Sleep Breath 11:69–76

    Article  PubMed  Google Scholar 

  5. Bazan JF, Bacon KB, Hardiman GJ (1997) A new class of membrane bound chemokine with a CX3C motif. Nature 385:640–644

    Article  PubMed  CAS  Google Scholar 

  6. Liu H, Jiang D (2011) Fractalkine/CX3CR1 and atherosclerosis. Clinica Chimica Acta 412:1180–1186

    Article  CAS  Google Scholar 

  7. Volin MV, Woods JM, Amin MA, Connors MA, Harlow LA, Koch AE (2001) Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. Am J Pathol 159:1521–1530

    Article  PubMed  CAS  Google Scholar 

  8. Efsen E, Grappone C, DeFranco RM, Milani S, Romanelli RG, Bonacchi A, Caligiuri A, Failli P, Annunziato F, Pagliai G, Pinzani M, Laffi G, Gentilini P, Marra F (2002) Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. J Hepatol 37:39–47

    Article  PubMed  CAS  Google Scholar 

  9. Robinson LA, Nataraj C, Thomas DW, Howell DN, Griffiths R, Bautch V, Patel DD, Feng L, Coffman TM (2000) A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol 165:6067–6072

    PubMed  CAS  Google Scholar 

  10. Mills PJ, Dimsdale JE (2004) Sleep apnea: a model for studying cytokines, sleep and sleep disruption. Brain Behav Immun 18:298–303

    Article  PubMed  CAS  Google Scholar 

  11. Chen XJ, Cheng DY, Yang L, Xia XQ, Guan J (2006) Effect of breviscapine on fractalkine expression in chronic hypoxica rats. Chin Med J 119:1465–1468

    PubMed  CAS  Google Scholar 

  12. American Academy of Sleep Medicine Task Force (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667–689

    Google Scholar 

  13. Kerfoot SM, Lord SE, Bell RB, Gill V, Robbins SM, Kubes P (2003) Human fractalkine mediates leukocyte adhesion but not capture under physiological shear conditions: a mechanism for selective monocyte recruitment. Eur J Immunol 33:729–739

    Article  PubMed  CAS  Google Scholar 

  14. Umehara H, Goda S, Imai T, Nagano Y, Minami Y, Tanaka Y, Okazaki T, Bloom ET, Domae N (2001) Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1. Immunol Cell Biol 79:298–302

    Article  PubMed  CAS  Google Scholar 

  15. Vitale S, Schmid-Alliana A, Breuil V, Pomeranz M, Millet MA, Rossi B, Schmid-Antomarchi H (2004) Soluble fractalkine prevents monocyte chemoattractant protein-1-induced monocyte migration via inhibition of stressactivated protein kinase 2/p38 and matrix metalloproteinase activities. J Immunol 172:585–592

    PubMed  CAS  Google Scholar 

  16. Cambien B, Pomeranz M, Schmid-Antomarchi H, Millet MA, Breittmayer V, Rossi B, Schmid-Alliana A (2001) Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood 97:2031–2037

    Article  PubMed  CAS  Google Scholar 

  17. Volin MV, Huynh N, Klosowska K, Reyes RD, Woods JM (2010) Fractalkine-induced endothelial cell migration requires MAP kinase signaling. Pathobiology 77:7–16

    Article  PubMed  CAS  Google Scholar 

  18. Geissmann F, Jung S, Littmann DR (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71–82

    Article  PubMed  CAS  Google Scholar 

  19. Barlic J, Zhang Y, Foley JF, Murphy PM (2006) Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor {gamma}-dependent pathway. Circulation 114:807–819

    Article  PubMed  CAS  Google Scholar 

  20. Yang XP, Jones RA, Rivers JH, Chen G, Cai Z, Fox-Talbot K, Irani K, Becker LC (2007) Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak-Stat5 pathway. Circ Res 101:1001–1008

    Article  PubMed  CAS  Google Scholar 

  21. Chandrasekar B, Mummidi S, Perla RP, Bysani S, Dulin NO, Liu F, Melby PC (2003) Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway. Biochem J 373:547–558

    Article  PubMed  CAS  Google Scholar 

  22. Kansra V, Groves C, Gutierrez Ramos JC, Polakiewicz RD (2001) Phosphatidylinositol 3-kinase- dependent extracellular calcium influx is essential for CX(3)CR1-mediated activation of the mitogen-activated protein kinase cascade. J Biol Chem 276:31831–31838

    Article  PubMed  CAS  Google Scholar 

  23. Yoneda O, Imai T, Goda S, Inoue H, Yamauchi A, Okazaki T (2000) Fractalkine-mediated endothelial cell injury by NK cells. J Immunol 164:4055–4062

    PubMed  CAS  Google Scholar 

  24. Foussat A, Coulomb-L'Hermine A, Gosling J, Krzysiek R, Durand-Gasselin I, Schall T, Balian A, Richard Y, Galanaud P, Emilie D (2000) Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol 30:87–97

    Article  PubMed  CAS  Google Scholar 

  25. Nishimura M, Umehara H, Nakayama T, Yoneda O, Hieshima K, Kakizaki M, Dohmae N, Yoshie O, Imai T (2002) Dual functions of fractalkine/CX3CR1 in trafficking of circulating cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 138:6173–6180

    Google Scholar 

  26. White GE, Tan TC, John AE, Whatling C, McPheat WL, Greaves DR (2010) Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling. Cardiovasc Res 85:825–835

    Article  PubMed  CAS  Google Scholar 

  27. Schäfer A, Schulz C, Eigenthaler M, Fraccarollo D, Kobsar A, Gawaz M, Ertl G, Walter U, Bauersachs J (2004) Novel role of the membrane bound chemokine fractalkine in platelet activation and adhesion. Blood 103:407–412

    Article  PubMed  Google Scholar 

  28. Schulz C, Schäfer A, Stolla M, Kerstan S, Lorenz M, von Brühl ML, Schiemann M, Bauersachs J, Gloe T, Busch DH, Gawaz M, Massberg S (2007) Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation 116:764–773

    Article  PubMed  CAS  Google Scholar 

  29. McDermott DH, Fong AM, Yang Q, Sechler JM, Cupples LA, Merrell MN, Wilson PW, D'Agostino RB, O'Donnell CJ, Patel DD, Murphy PM (2003) Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest 111:1241–1246

    PubMed  CAS  Google Scholar 

  30. Moatti D, Faure S, Fumeron F, Mel-W A, Seknadji P, McDermott DH, Debré P, Aumont MC, Murphy PM, de Prost D, Combadière C (2001) Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97:1925–1928

    Article  PubMed  CAS  Google Scholar 

  31. Shah R, Hinkle CC, Ferguson JF, Mehta NN, Li M, Qu L, Lu Y, Putt ME, Ahima RS, Reilly MP (2011) Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Diabetes 60:1512–1518

    Article  PubMed  CAS  Google Scholar 

  32. Vgontzas AN, Bixler EO, Chrousos GP (2005) Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9:211–224

    Article  PubMed  Google Scholar 

  33. Tam CS, Wong M, McBain R, Bailey S, Waters KA (2006) Inflammatory measures in children with obstructive sleep apnoea. J Paediatr Child Health 42:277–282

    Article  PubMed  Google Scholar 

  34. Ludwig A, Berkhout T, Moores K, Groot P, Chapman G (2002) Fractalkine is expressed by smooth muscle cells in response to IFN-gamma and TNF-alpha and is modulated by metalloproteinase activity. J Immunol 168:604–612

    PubMed  CAS  Google Scholar 

  35. Garcia GE, Xia Y, Chen S, Wang Y, Ye RD, Harrison JK, Bacon KB, Zerwes HG, Feng L (2000) NF-κB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1β, TNF-α, and LPS. J Leukoc Biol 67:577–584

    PubMed  CAS  Google Scholar 

  36. Lin CM, Davidson TM, Ancoli-Israel S (2008) Gender differences in obstructive sleep apnea and treatment implications. Sleep Med Rev 12:481–496

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by National Scientific Fund of PR China (no. 81100059) and National Scientific Fund of PR China (no. 30700890).

Author information

Authors and Affiliations

  1. Department of Geriatrics, The Second Xiangya Hospital of Central South University, Middle Ren-Min Road No.139, Changsha, Hunan, 410011, People’s Republic of China

    Yina Wang, Yingquan Luo, Yue Yang & Yu Yang

  2. Department of Surgery, The Third Xiangya Hospital of Central South University, Tong-ZiPo Road No.138, Changsha, Hunan, 410013, People’s Republic of China

    Yayong Li

  3. Department of Respiratory Medicine, The Second Xiangya Hospital of Central South University, Middle Ren-Min Road No.139, Changsha, Hunan, 410011, People’s Republic of China

    Ping Chen

Authors
  1. Yina Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yayong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ping Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yingquan Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yue Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yu Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yu Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Y., Li, Y., Chen, P. et al. Elevated fractalkine in patients with obstructive sleep apnea hypopnea syndrome. Sleep Breath 17, 203–208 (2013). https://doi.org/10.1007/s11325-012-0674-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-012-0674-6

Keywords

Search

Navigation